Dexcom Inc (DXCM)

$115.23 3.54 (2.98%)

16:00 EDT DXCM Stock Quote Delayed 30 Minutes

The 3 Best MedTech Stocks to Buy Now: May 2024

By Shane Neagle, InvestorPlace Contributor May 29, 2024

Explore the best MedTech stocks to buy now that are driven by AI's potential to revolutionize healthcare efficiency.

3 Growth Stocks the New ‘GPT-4o’ AI Bot Says Will Make You Rich

Shhh! 3 Secret IoT Stocks Flying Below Wall Street’s Radar

DXCM Stock Earnings: DexCom Beats EPS, Beats Revenue for Q1 2024

Volume:

Previous Close -

Market Cap 11.15B

PE Ratio 74.82

EPS 1.54

Volume (Avg. Vol.) 4.06M

Day's Range $114.33 - $118.38

52-Week Range $74.75 - $142.00

Dividend & Yield N/A (N/A)

DXCM Stock Predictions, Articles, and Dexcom Inc News

From InvestorPlace
From the Web

Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024

By Larry Ramer, InvestorPlace Contributor Apr 25, 2024

The medical device market is growing fast, and top medical device firms can become takeover targets. Here are three medtech stocks to watch.

Nasdaq Nightmares: 3 Stocks to Sell Before Reality Sets In

By Stavros Tousios, InvestorPlace Contributor Apr 10, 2024

DoorDash, DexCom, and Advanced Micro Devices are three Nasdaq stocks to sell before reality sets in as exuberance may be fading.

3 Obesity Drug Stocks Set to Skyrocket as Demand Goes Wild

By Shane Neagle, InvestorPlace Contributor Apr 10, 2024

Discover top obesity drug stocks set to soar as demand surges. Eli Lilly, Novo Nordisk, & Dexcom lead with revolutionary treatments

7 Nasdaq Stocks to Sell in April Before They Crash & Burn

By Ian Bezek, InvestorPlace Contributor Apr 3, 2024

The momentum in growth companies is likely to run out. Move on from these Nasdaq stocks to sell in April before it's too late.

3 Overvalued S&P 500 Stocks for Your ‘Do NOT Buy’ List

By Will Ashworth, InvestorPlace Contributor Apr 1, 2024

The S&P 500’s current P/E ratio is 30% higher than a year ago, making it easier to find overvalued S&P 500 stocks to buy.

More Than 86% of Analysts Who Cover These 3 Stocks Rate Them a ‘Buy’

By Rich Duprey, InvestorPlace Contributor Mar 25, 2024

Investors should take notice of these stocks with high analyst ratings. It's time to load up your portfolio.

3 Telehealth Stocks With Room to Run in 2024

By Muslim Farooque, InvestorPlace Contributor Feb 29, 2024

Embrace 2024's leading telehealth stocks to buy, merging cutting-edge care with smart investing for a lucrative portfolio.

7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution

By Alex Sirois, InvestorPlace Contributor Feb 14, 2024

Obesity drug sales boomed in 2023 and will continue in 2024 making these weight loss stocks attratcive considerations for pharma investors.

3 Mid-Cap Stocks Poised for a Breakout in 2024

By Alex Sirois, InvestorPlace Contributor Jan 16, 2024

Mid-cap stocks are expected to have a breakout year especially in light of their underperformance in 2023 with these equities looking strong.

The 3 Best Growth Stocks to Buy in January 2024

By Charles Munyi, InvestorPlace Contributor Jan 14, 2024

The best growth stocks to buy for 2024 with an impressive growth history and solid long-term tailwinds to support 30% EPS growth.

3 Stocks to Capitalize on the Telehealth Explosion

By Ian Bezek, InvestorPlace Contributor Jan 8, 2024

These three telehealth stocks are leading the way for improved telehealth offerings, highlighted after the pandemic.

3 Earnings Winners Poised to Outperform the Market

By Rick Orford, InvestorPlace Contributor Nov 9, 2023

Discover three earnings winners that beat estimates and could help you beat the market, too. Which ones will you add to your portfolio?

3 Healthcare Stocks Getting Help From the Aging Population

By Larry Ramer, InvestorPlace Contributor Nov 6, 2023

America's aging population needs chronic conditions treatments, and these healthcare stocks are growing in the quest for healing solutions.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Oct 27, 2023

It's time to start off the final trading day this week with a breakdown of the biggest pre-market stock movers on Friday!

The 7 Best Nasdaq Stocks To Buy Now: October 2023

By Alex Sirois, InvestorPlace Contributor Oct 19, 2023

The best Nasdaq stocks go much deeper than the magnificent 7 and offer surprising stability in addition to broad exposure to AI.

Glucose Game-Changers: 3 Diabetes Stocks to Grab on the Downturn

By Larry Ramer, InvestorPlace Contributor Oct 4, 2023

Diabetes stocks have retreated excessively on the belief that a new weight-loss drug will greatly reduce the number of diabetes patients.

3 Healthcare Stocks That Should Be on Every Investor’s Radar This Fall

By Will Ashworth, InvestorPlace Contributor Sep 23, 2023

Nonetheless, if you can only have one sector ETF in your investment portfolio, it should be healthcare

3 Unstoppable Nasdaq 100 Stocks Just Waiting to Be Bought

By Rich Duprey, InvestorPlace Contributor Sep 21, 2023

Yet just as quickly, it made a U-turn and more than doubled again over the next 18 months.

7 Top Stock Opportunities on the Heels of the Latest Jobs Report

By Alex Sirois, InvestorPlace Contributor Aug 20, 2023

These 7 stocks to buy for the jobs report look to be in strong position as the economy cools and inflation slides.

What Are the Best Companies to Invest in Now? Our 3 Picks for August

By Michael Que, InvestorPlace Contributor Aug 10, 2023

After you after the best companies to invest in? Here are the best picks for the month of August that you can't afford to miss.

Google Parent Alphabet Is Selling Shares of 2 Hypergrowth Stocks and Piling Into a Promising Artificial Intelligence (AI) Company

From The Motley Fool May 23, 2024

Alphabet oversees more than $2.5 billion of invested assets. In the March quarter, it dumped shares of two of its largest holdings and nearly quadrupled its stake in a fast-growing artificial intelligence (AI) stock.

Bull Market and Beyond: 2 Stocks Just Waiting to Soar

From The Motley Fool May 13, 2024

Patience often pays off in the equity markets.

NASDAQ:DXCM: a strong growth stock preparing for the next leg up?.

From Chartmill May 7, 2024

DEXCOM INC (NASDAQ:DXCM), a strong growth stock, setting up for a breakout.

Dexcom Inc (DXCM)

The 3 Best MedTech Stocks to Buy Now: May 2024

3 Growth Stocks the New ‘GPT-4o’ AI Bot Says Will Make You Rich

Shhh! 3 Secret IoT Stocks Flying Below Wall Street’s Radar

DXCM Stock Earnings: DexCom Beats EPS, Beats Revenue for Q1 2024

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Dexcom Inc (DXCM)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

DXCM Stock Predictions, Articles, and Dexcom Inc News

Subscriber Sign in